Enhanced CD8+ T Cell Immune Responses and Protection Elicited against Plasmodium berghei Malaria by Prime Boost Immunization Regimens Using a Novel Attenuated Fowlpox Virus

Journal of Immunology

Volumn 172, Issue 5, 2004, Pages 3094-3100

  Anderson, Richard J ^a,e   Hannan, Carolyn M ^b   Gilbert, Sarah C ^a   Laidlaw, Stephen M ^c   Sheu, Eric G ^b   Korten, Simone ^b   Sinden, Robert ^d   Butcher, Geoffrey ^d   Skinner, Michael A ^c   Hill, Adrian V S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Oxxon Pharmaccines Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; CIRCUMSPOROZOITE PROTEIN; DNA VACCINE; GAMMA INTERFERON; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKEN; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; FOWLPOX VIRUS; GENE VECTOR; HOMOLOGOUS RECOMBINATION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LIVER CELL; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS STRAIN;

EID: 10744224195     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.5.3094     Document Type: Article

References (44)

1. Sachs, J., and P. Malaney. 2002. The economic and social burden of malaria. Nature 415:680.
2. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453.
3. Hoffman, S. L., L. M. Goh, T. C. Luke, I. Schneider, T. P. Le, D. L. Doolan, J. Sacci, P. de la Vega, M. Dowler, C. Paul, et al. 2002. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185:1155.
4. + cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 3:579.
5. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323.
6. Sedegah, M., R. Hedstrom, P. Hobart, and S. L. Hoffman. 1994. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc. Natl. Acad. Sci. USA 91:9866.
7. Allsopp, C. E., M. Plebanski, S. Gilbert, R. E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, E. Paoletti, et al. 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26:1951.
8. Gilbert, S. C., M. Plebanski, S. J. Harris, C. E. Allsopp, R. Thomas, G. T. Layton, and A. V. Hill. 1997. A protein particle vaccine containing multiple malaria epitopes. Nat. Biotechnol. 15:1280.
9. + T cell-mediated protective immunity against malaria. J. Immunol. 158:1268.
10. + T and B cell epitopes: comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 153:4636.
11. Tsuji, M., C. C. Bergmann, Y. Takita-Sonoda, K. Murata, E. G. Rodrigues, R. S. Nussenzweig, and F. Zavala. 1998. Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice. J. Virol. 72:6907.
12. Lanar, D. E., J. A. Tine, C. de Taisne, M. C. Seguin, W. I. Cox, J. P. Winslow, L. A. Ware, E. B. Kauffman, D. Gordon, W. R. Ballou, et al. 1996. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect. Immun. 64:1666.
13. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat. Med. 4:397.
14. Gilbert, S. C., J. Schneider, C. M. Hannan, J. T. Hu, M. Plebanski, R. Sinden, and A. V. Hill. 2002. Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes. Vaccine 20:1039.
15. Bruna-Romero, O., G. Gonzalez-Aseguinolaza, J. C. Hafalla, M. Tsuji, and R. S. Nussenzweig. 2001. Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc. Natl. Acad. Sci. USA 98:11491.
16. + T cell immunogenicity and protective efficacy in the influenza and malaria models. Vaccine 18:623.
17. Sedegah, M., T. R. Jones, M. Kaur, R. Hedstrom, P. Hobart, J. A. Tine, and S. L. Hoffman. 1998. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc. Natl. Acad. Sci. USA 95:7648.
18. McConkey, S. J., W. H. Reece, V. S. Moorthy, D. Webster, S. Dunachie, G. Butcher, J. M. Vuola, T. J. Blanchard, P. Gothard, K. Watkins, et al. 2003. Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat. Med. 9:729.
19. Boyle, D. B., and H. G. Heine. 1993. Recombinant fowlpox virus vaccines for poultry. Immunol. Cell Biol. 71:391.
20. Paoletti, E. 1996. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. USA 93:11349.
21. Taylor, J., and E. Paoletti. 1988. Fowlpox virus as a vector in non-avian species. Vaccine 6:466.
22. Taylor, J., R. Weinberg, Y. Kawaoka, R. G. Webster, and E. Paoletti. 1988. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6:504.
23. Taylor, J., R. Weinberg, B. Languet, P. Desmettre, and E. Paoletti. 1988. Recombinant fowlpox virus inducing protective immunity in non-avian species. Vaccine 6:497.
24. Grosenbach, D. W., J. C. Barrientos, J. Schlom, and J. W. Hodge. 2001. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects. Cancer Res. 61:4497.
25. Irvine, K. R., R. S. Chamberlain, E. P. Shulman, D. R. Surman, S. A. Rosenberg, and N. P. Restifo. 1997. Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors. J. Natl. Cancer Inst. 89:1595.
26. Restifo, N. P., B. R. Minev, A. S. Taggarse, B. J. McFarland, M. Wang, and K. R. Irvine. 1994. Enhancing the recognition of tumour associated antigens. Folia Biol. (Praha) 40:74.
27. Wang, M., V. Bronte, P. W. Chen, L. Gritz, D. Panicali, S. A. Rosenberg, and N. P. Restifo. 1995. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen. J. Immunol. 154:4685.
28. Kent, S. J., A. Zhao, S. J. Best, J. D. Chandler, D. B. Boyle, and I. A. Ramshaw. 1998. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72:10180.
29. + T cell response in mice using a fowlpox virus vector expressing an HIV-1 multi-CTL-epitope polypeptide. Viral Immunol. 15:337.
30. Robinson, H. L., D. C. Montefiori, R. P. Johnson, M. L. Kalish, S. L. Lydy, and H. M. McClure. 2000. DNA priming and recombinant pox virus boosters for an AIDS vaccine. Dev. Biol. (Basel) 104:93.
31. Mayr, A., and K. Malicki. 1966. [Attenuation of virulent fowl pox virus in tissue culture and characteristics of the attenuated virus.] Zentralbl. Veterinarmed. B 13:1.
32. Mockett, B., M. M. Binns, M. E. Boursnell, and M. A. Skinner. 1992. Comparison of the locations of homologous fowlpox and vaccinia virus genes reveals major genome reorganization. J. Gen. Virol. 73:2661.
33. Qingzhong, Y., T. Barrett, T. D. Brown, J. K. Cook, P. Green, M. A. Skinner, and D. Cavanagh, 1994. Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F). Vaccine 12:569.
34. Altman, J. D., P. A. Moss, P. J. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, and M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
35. Brown, M., Y. Zhang, S. Dermine, E. A. de Wynter, C. Hart, H. Kitchener, P. L. Stern, M. A. Skinner, and S. N. Stacey. 2000. Dendritic cells infected with recombinant fowlpox virus vectors are potent and long-acting stimulators of transgene-specific class I restricted T lymphocyte activity, Gene Ther. 7:1680.
36. Ramirez, J. C., M. M. Gherardi, and M. Esteban. 2000. Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J. Virol. 74:923.
37. + T cell immune response against a V3 loop multi-epitope polypeptide (TAB 13) of HIV-1 Env after priming with purified fusion protein and booster with modified vaccinia virus Ankara (MVA-TAB) recombinant: a comparison of humoral and cellular immune responses with the vaccinia virus Western Reserve (WR) vector. Vaccine 20:961.
38. Afonso, C. L., E. R. Tulman, Z. Lu, L. Zsak, G. F. Kutish, and D. L. Rock. 2000. The genome of fowlpox virus. J. Virol. 74:3815.
39. Hertig, C., B. E. Coupar, A. R. Gould, and D. B. Boyle. 1997. Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 235:367.
40. Plebanski, M., S. C. Gilbert, J. Schneider, C. M. Hannan, G. Layton, T. Blanchard, M. Becker, G. Smith, G. Butcher, R. E. Sinden, and A. V. Hill. 1998. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 28:4345.
41. Good, M. F., and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11:412.
42. Krzych, U., R. Schwenk, M. Guebre-Xabier, P. Sun, D. Palmer, K. White, and I. Chalom. 2000. The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites. Immunol. Rev 174:123.
43. Yoshida, S., S. I. Kashiwamura, Y. Hosoya, E. Luo, H. Matsuoka, A. Ishii, A. Fujimura, and E. Kobayashi, 2000, Direct immunization of malaria DNA vaccine into the liver by gene gun protects against lethal challenge of Plasmodium berghei sporozoite. Biochem. Biophys. Res. Commun. 271:107.
44. Laidlaw, S. M., and M. A. Skinner. Comparison of the genome sequence of FP9. an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses. J. Gen. Virol. In press.